Woodline Partners’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.7M | Buy |
4,615,676
+51
| +0% | +$449 | 0.21% | 134 |
|
|
2025
Q1 | $34.6M | Buy |
4,615,625
+476,032
| +11% | +$3.57M | 0.22% | 140 |
|
|
2024
Q4 | $34.5M | Buy |
4,139,593
+90,940
| +2% | +$758K | 0.23% | 136 |
|
|
2024
Q3 | $28.1M | Buy |
4,048,653
+2,901,070
| +253% | +$20.1M | 0.24% | 138 |
|
|
2024
Q2 | $5.62M | Buy |
1,147,583
+137,966
| +14% | +$676K | 0.05% | 328 |
|
|
2024
Q1 | $5.86M | Buy |
+1,009,617
| New | +$5.86M | 0.05% | 340 |
|